These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3141672)

  • 41. Alfacalcidol reduces accelerated bone turnover in elderly women with osteoporosis.
    Shiraki M; Fukuchi M; Kiriyama T; Okamoto S; Ueno T; Sakamoto H; Nagai T
    J Bone Miner Metab; 2004; 22(4):352-9. PubMed ID: 15221494
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The anabolic effects of human parathyroid hormone (hPTH) on rat vertebral body mass are also reflected in the quality of bone, assessed by biomechanical testing: a comparison study between hPTH-(1-34) and hPTH-(1-84).
    Mosekilde L; Søgaard CH; Danielsen CC; Tørring O
    Endocrinology; 1991 Jul; 129(1):421-8. PubMed ID: 2055197
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intermittent treatment with human parathyroid hormone (hPTH[1-34]) increased trabecular bone volume but not connectivity in osteopenic rats.
    Lane NE; Thompson JM; Strewler GJ; Kinney JH
    J Bone Miner Res; 1995 Oct; 10(10):1470-7. PubMed ID: 8686502
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of risedronate on bone turnover markers in osteoporotic postmenopausal women: comparison of two protocols of treatment.
    Bahlous A; Bouzid K; Sahli H; Sallami S; Abdelmoula J
    Tunis Med; 2009 Jun; 87(6):380-1. PubMed ID: 19927782
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anabolic effect of low doses of a fragment of human parathyroid hormone on the skeleton in postmenopausal osteoporosis.
    Reeve J; Hesp R; Williams D; Hulme P; Klenerman L; Zanelli JM; Darby AJ; Tregear GW; Parsons JA
    Lancet; 1976 May; 1(7968):1035-8. PubMed ID: 57447
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) on the ultrastructure of parathyroid glands and plasma immunoreactive parathyroid hormone in pregnant cows fed a low calcium diet.
    Yarrington JT; Capen CC; Black HE; Re R; Potts JT; Geho WB
    Lab Invest; 1977 Apr; 36(4):402-12. PubMed ID: 191694
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical significance of risedronate for osteoporosis in the initial treatment of male patients with Graves' disease.
    Majima T; Komatsu Y; Doi K; Takagi C; Shigemoto M; Fukao A; Morimoto T; Corners J; Nakao K
    J Bone Miner Metab; 2006; 24(2):105-13. PubMed ID: 16502116
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rapid increase in bone mineral density in a child with osteoporosis and autoimmune hypoparathyroidism treated with PTH 1-34.
    Koch CA
    Exp Clin Endocrinol Diabetes; 2001; 109(6):350-4. PubMed ID: 11571675
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Osteoporosis: trials and tribulations.
    Seeman E
    Am J Med; 1997 Aug; 103(2A):74S-87S; discussion 87S-89S. PubMed ID: 9302899
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The course of hypercalciuria and related markers of bone metabolism parameters associated with corticosteroid treatment.
    Duzen O; Erkoc R; Begenik H; Soyoral YU; Aldemir MN
    Ren Fail; 2012; 34(3):338-42. PubMed ID: 22260330
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cyclical etidronate reverses bone loss of the spine and proximal femur in patients with established corticosteroid-induced osteoporosis.
    Struys A; Snelder AA; Mulder H
    Am J Med; 1995 Sep; 99(3):235-42. PubMed ID: 7653482
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of cyclic versus daily hPTH(1-34) regimens on bone strength in association with BMD, biochemical markers, and bone structure in mice.
    Iida-Klein A; Hughes C; Lu SS; Moreno A; Shen V; Dempster DW; Cosman F; Lindsay R
    J Bone Miner Res; 2006 Feb; 21(2):274-82. PubMed ID: 16418783
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The potential of parathyroid hormone as a therapy for osteoporosis.
    Rubin MR; Bilezikian JP
    Int J Fertil Womens Med; 2002; 47(3):103-15. PubMed ID: 12081255
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Priliminary trial of low doses of human parathyroid hormone 1-34 peptide in treatment of osteoporosis.
    Reeve J; Tregear GW; Parsons JA
    Calcif Tissue Res; 1976 Aug; 21 Suppl():469-77. PubMed ID: 782668
    [No Abstract]   [Full Text] [Related]  

  • 55. Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism.
    Rossini M; Gatti D; Isaia G; Sartori L; Braga V; Adami S
    J Bone Miner Res; 2001 Jan; 16(1):113-9. PubMed ID: 11149474
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [New drugs with positive effects on bones].
    Zofková I; Kanceva RL
    Cas Lek Cesk; 1997 Jul; 136(15):459-63. PubMed ID: 9340191
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A comparison of incidences of vertebral fracture in Japanese patients with involutional osteoporosis treated with risedronate and etidronate: a randomized, double-masked trial.
    Kushida K; Fukunaga M; Kishimoto H; Shiraki M; Itabashi A; Inoue T; Kaneda K; Morii H; Nawata H; Yamamoto K; Ohashi Y; Orimo H
    J Bone Miner Metab; 2004; 22(5):469-78. PubMed ID: 15316868
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prolonged treatments with antiresorptive agents and PTH have different effects on bone strength and the degree of mineralization in old estrogen-deficient osteoporotic rats.
    Cheng Z; Yao W; Zimmermann EA; Busse C; Ritchie RO; Lane NE
    J Bone Miner Res; 2009 Feb; 24(2):209-20. PubMed ID: 18847326
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Alendronate prevents further bone loss in renal transplant recipients.
    Giannini S; D'Angelo A; Carraro G; Nobile M; Rigotti P; Bonfante L; Marchini F; Zaninotto M; Dalle Carbonare L; Sartori L; Crepaldi G
    J Bone Miner Res; 2001 Nov; 16(11):2111-7. PubMed ID: 11697808
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diphosphonate therapy of paget's disease of bone.
    Canfield R; Rosner W; Skinner J; McWhorter J; Resnick L; Feldman F; Kammerman S; Ryan K; Kunigonis M; Bohne W
    J Clin Endocrinol Metab; 1977 Jan; 44(1):96-106. PubMed ID: 401827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.